AGMB
AGMB
Positions held
Your positionsAGMB isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Agomab stock jumps on positive trial data
2026-09-11 · Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
2026-09-03 · Agomab to Participate in Upcoming Investor Conferences
2026-08-19 · Cantor Fitzgerald Initiates AgomAb Therapeutics at Overweight
2026-08-10 · Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
2026-08-06 · Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
2026-07-23 · B. Riley Initiates AgomAb Therapeutics at Buy With $34 Price Target
Price (daily)
Full chart · RSI · MACD · patterns